Woolf-May K, Ferrett D
Canterbury Christ Church University, North Holrnes Road, Canterbury, Kent CT1 1QU, UK.
Br J Sports Med. 2008 Jan;42(1):36-41; discussion 41. doi: 10.1136/bjsm.2006.034116. Epub 2007 Jun 29.
Comorbidities are found to affect metabolic equivalents (METs). Therefore the main objective of this study was to compare METs (1 MET: oxygen uptake (Vo(2)) 3.5 ml/kg/min) during an incremental shuttle walking test (SWT) between non-cardiac and post-myocardial infarction (MI) men, and secondly to determine any differences in Vo(2) (ml/kg/min) between flat treadmill walking and the turning during the shuttle walking in non-cardiac subjects.
Comparative study.
Thirty one post-MI (mean (SD) age 63.5 (6.5), range 53-77 years) from phase IV cardiac rehabilitation and 19 non-cardiac (64.6 (7.5), range 51-76 years) men participated.
All subjects performed an SWT, and non-cardiac subjects a treadmill test of similar protocol. Throughout both, the subject's Vo(2) was measured.
Analysis comparing lines of regression showed METs at 1.12 to 4.16 mph were higher (p<0.001) for post-MIs versus non-cardiac subjects. For non-cardiac subjects, there were no differences between the treadmill test and SWT (p>0.9) and LoA showed acceptable agreement in METs between treadmill vs SWT, mean difference -1.1 (8.8) (1.96SD).
It would appear that for asymptomatic individuals it is appropriate to apply established METs for flat walking to the SWT. However, the significantly higher METs for the post-MI compared with the non-cardiac subjects indicates the need for caution when using METs derived from healthy subjects in the prescription of exercise for myocardial patients.
发现合并症会影响代谢当量(METs)。因此,本研究的主要目的是比较非心脏疾病男性与心肌梗死后(MI)男性在递增式往返步行试验(SWT)期间的代谢当量(1个代谢当量:摄氧量(Vo₂)3.5毫升/千克/分钟),其次是确定非心脏疾病受试者在平板跑步机行走和往返步行转弯期间的Vo₂(毫升/千克/分钟)差异。
比较研究。
31名来自心脏康复IV期的心肌梗死后患者(平均(标准差)年龄63.5(6.5)岁,范围53 - 77岁)和19名非心脏疾病男性(64.6(7.5)岁,范围51 - 76岁)参与研究。
所有受试者均进行了递增式往返步行试验,非心脏疾病受试者进行了类似方案的跑步机测试。在整个过程中,测量受试者的Vo₂。
回归直线比较分析显示,心肌梗死后患者在速度为1.12至4.16英里/小时时的代谢当量高于非心脏疾病受试者(p < 0.001)。对于非心脏疾病受试者,跑步机测试和递增式往返步行试验之间没有差异(p > 0.9),一致性界限显示跑步机测试和递增式往返步行试验在代谢当量方面具有可接受的一致性,平均差异为 -1.1(8.8)(1.96标准差)。
对于无症状个体,将既定的平板步行代谢当量应用于递增式往返步行试验似乎是合适的。然而,与非心脏疾病受试者相比,心肌梗死后患者的代谢当量明显更高,这表明在为心肌疾病患者制定运动处方时,使用来自健康受试者的代谢当量时需要谨慎。